Bemotrizinol Gets FDA Approval: What the Evidence Says About the First New Sunscreen Ingredient in 20 Years

Sunscreen bottles and tubes on a beach towel in sunlight
Bemotrizinol (BEMT) has been available in European and Asian sunscreens since around 2000. The FDA’s June 2026 GRASE designation makes it the first new active sunscreen ingredient approved in the US in over two decades, and the first organic filter to clear that bar at all.

The United States sunscreen market has been functionally frozen since 1999. While European and Asian consumers have had access to a broader menu of UV filters, including more photostable options with stronger UVA coverage, US products have been limited to a short list of ingredients whose regulatory review under the FDA’s OTC monograph system stalled or stopped entirely. Twelve chemical filters have been sitting in regulatory limbo since 2019, designated by the FDA as having “insufficient data” to determine safety and effectiveness. Only zinc oxide and titanium dioxide hold GRASE (Generally Recognized as Safe and Effective) status.

On June 9, 2026, the FDA added a third: bemotrizinol, also called BEMT or by its trade name Parsol Shield, became the first organic UV filter to receive GRASE designation, and the first new sunscreen active ingredient approved in the US in more than 20 years. The announcement drew wide coverage and significant enthusiasm from dermatologists who have long argued US consumers were being underserved by the available filter options.

The question worth asking before the enthusiasm runs ahead of the evidence: what does the data actually show about bemotrizinol, and what are the real limits of what this approval means for consumers?

What Bemotrizinol Is and How It Works

Bemotrizinol is an organic (chemical) UV filter developed in the late 1990s. It belongs to a class of filters that work primarily by absorbing UV radiation and releasing the captured energy as heat, rather than reflecting or scattering it the way mineral filters (zinc oxide, titanium dioxide) do. In this respect it is mechanistically similar to other organic filters already in US sunscreens, such as avobenzone and oxybenzone.

What distinguishes BEMT from those filters is its coverage profile and structural stability. It is a broad-spectrum filter, absorbing across both UVB and UVA wavelengths, with particularly strong absorption in the longer UVA range (UVA1, roughly 340–400 nm) that is associated with photoaging and deeper skin damage. This is a meaningful gap in the current US lineup: avobenzone covers UVA but is photounstable, degrading meaningfully under sunlight exposure; oxybenzone covers both ranges but has raised safety concerns around systemic absorption.

BEMT’s photostability is one of its practical advantages. It degrades less under sun exposure than avobenzone, meaning a BEMT-containing formulation maintains its protective activity longer between reapplications. This does not eliminate the need to reapply, but it does address a known weakness of avobenzone-based products.

On safety, the structural feature most relevant to the FDA’s evaluation is molecular size. BEMT’s chromophores (the light-absorbing molecular units) are large, exceeding the 500-dalton threshold that pharmacologists use as a rough predictor of skin penetration. Molecules above this size are generally considered unlikely to cross the stratum corneum in meaningful amounts. This is the primary structural argument for low systemic absorption, in contrast to smaller-molecule filters like oxybenzone, which has been detected in blood and urine at measurable concentrations after sunscreen application (Matta et al., JAMA 2019; 2020).

The FDA approved BEMT at concentrations up to 6%. Because of this cap, it is expected to be used in combination with other filters rather than as a standalone ingredient in most formulations.

Why It Took 20 Years to Reach the US

Bemotrizinol has been available in European sunscreens since approximately 2000, giving it a real-world safety record across diverse populations spanning more than two decades. Its delay in reaching the US market is not a story about inadequate evidence; it is a story about regulatory process.

Sunscreen active ingredients are regulated in the US as OTC drugs, not cosmetics. New ingredients require full GRASE determination under the FDA’s monograph system, a process that has historically been slow and resource-intensive. The Sunscreen Innovation Act of 2014 (Public Law 113-195) was specifically designed to accelerate review of the backlog of pending sunscreen ingredients, including BEMT. It did not produce the acceleration its sponsors anticipated. Twelve other chemical filters filed before or alongside BEMT remained classified as having insufficient data as of this approval, and have no clear timeline for resolution.

BEMT succeeded where others have not largely because the accumulated international evidence base became difficult to dismiss. Decades of post-market use across millions of consumers in Europe and Asia, with no significant safety signal emerging, provided the kind of real-world data that can substitute for the formal US-based studies the monograph process would otherwise require.

DSM Nutritional Products, the company that markets BEMT as Parsol Shield, submitted the application and receives an 18-month market exclusivity window as the first approved supplier. Broad market availability will follow, but not immediately.

How It Compares to Existing US Sunscreen Ingredients

The practical significance of the BEMT approval is best understood by comparison. The table below summarizes how it stacks up against the filters most commonly found in US products.

Ingredient UV Coverage Photostability GRASE Status Skin Penetration Concern
Bemotrizinol (BEMT) Broad (UVB + deep UVA) High Yes (2026) Low (>500 Da molecular weight)
Zinc oxide Broad (UVB + UVA) Excellent Yes Very low (mineral, non-nano)
Titanium dioxide UVB + some UVA Excellent Yes Very low (mineral, non-nano)
Avobenzone UVA only Low (degrades in sunlight) No Moderate
Oxybenzone UVB + UVA Moderate No Yes (detectable in bloodstream)
Octinoxate UVB only Moderate No Moderate

The key gap BEMT fills is broad-spectrum organic coverage with acceptable photostability and a more favorable penetration profile than oxybenzone. An Environmental Working Group analysis found that US sunscreens provide roughly 24% of SPF-labeled protection against UVA. The primary structural reason is avobenzone instability: the UVA filter most widely used in US chemical sunscreens degrades under the sun exposure it is supposed to block. BEMT directly addresses this, offering stronger and more stable UVA coverage as a drop-in alternative or complement.

Mineral sunscreens (zinc oxide, titanium dioxide) already offer excellent broad-spectrum coverage without the penetration concerns of organic filters. For consumers already using well-formulated mineral sunscreens, BEMT does not represent a meaningful upgrade. Its real value is for consumers who find mineral sunscreens cosmetically unacceptable (white cast, heavy texture) and currently rely on chemical filters with weaker or less stable UVA coverage.

The Claim

“Bemotrizinol provides superior broad-spectrum UV protection with an excellent safety profile, making it the best sunscreen active ingredient now available in the US.”

(Composite representative claim; reflects early marketing language and consumer coverage following the FDA announcement.)

What the Evidence Actually Shows

The broad-spectrum and photostability claims are well-supported. BEMT’s UV absorption profile is documented across decades of international use and in the peer-reviewed photochemistry literature. It absorbs more effectively across the UVA1 range than avobenzone at equivalent concentrations, and its higher photostability means that protection degrades less during extended outdoor exposure. These are genuine advantages over the organic filters currently dominating US chemical sunscreens.

The safety profile claim is also largely supported, though the evidence is mostly observational rather than from controlled trials. Twenty-plus years of post-market use in Europe and Asia without a significant adverse safety signal is meaningful real-world data. The molecular size argument for low penetration is structurally sound and has been the basis for similar assessments of other high-molecular-weight filters. The FDA evaluated formulations at up to 6%, including interaction effects with other sunscreen components, before granting GRASE status.

“Best sunscreen ingredient” is where the claim overreaches. BEMT does not outperform mineral sunscreens on any safety axis, and zinc oxide in particular retains advantages for UVA coverage without penetration concerns. BEMT is better characterized as the best organic broad-spectrum filter now available in the US, which is a meaningful but more specific claim.

What the Evidence Actually Shows

BEMT provides genuine improvements over currently available US organic filters, particularly for UVA1 coverage and photostability. The safety data, accumulated over two decades of international use, is substantial by the standards of real-world evidence. It is not meaningfully safer than mineral sunscreens, but it is a better-evidenced and more stable organic option than avobenzone, the current default UVA filter in US chemical sunscreens. The remaining unknowns are limited in scope: pool-water degradation by-products are not fully characterized, and US formulation experience is essentially zero.

The Caveats Worth Knowing

Four caveats deserve attention before the approval is treated as a complete win for US photoprotection.

First, pool-water degradation. Chlorination can break down BEMT, and the resulting by-products have not been fully characterized for skin safety. This is a real but narrow concern, most relevant to people applying sunscreen before swimming in chlorinated water. It does not affect normal outdoor use on dry skin, and it is common to many organic filters. But it is an open question that the international literature has not yet closed.

Second, market availability will lag. DSM’s 18-month exclusivity means only Parsol Shield-branded formulations will initially reach shelves. Wider incorporation into consumer products requires other manufacturers to license or wait out the exclusivity window, then reformulate and bring products to market. Most consumers will not see BEMT in accessible products for at least six to twelve months, and possibly longer for products at the price points that reach mass-market retail.

Third, US formulators have no practical experience with BEMT. Sunscreen formulation is as much chemistry as it is ingredient selection; how filters interact with each other and with the vehicle (the cream, lotion, or spray base) affects the final SPF, UVA protection factor, and skin feel. First-generation US products may not be optimized. European formulators have had two decades to learn BEMT’s behavior; US ones are starting from scratch.

Fourth, BEMT does not fix the broader US sunscreen landscape. Twelve other chemical filters remain in regulatory limbo with no GRASE designation and no clear timeline. The approval suggests the FDA can move on sunscreen modernization, which is a positive signal. It does not mean those filters are coming anytime soon.

Verdict: Supported

The BEMT approval is a genuine improvement for US consumers who rely on chemical sunscreens, backed by a substantial real-world safety record and a well-characterized UV absorption profile. The evidence supports the core claims: broad-spectrum coverage, better photostability than avobenzone, and a favorable penetration profile based on molecular size. The remaining unknowns (pool degradation by-products, first-generation US formulation quality) are real but limited in scope. One point withheld for those open questions and the practical reality that BEMT-containing products will not be meaningfully available to most US consumers for months. Evidence rating: 4/5.

What This Means for Consumers Right Now

Practically, not much for the next six to twelve months. BEMT products need time to reach shelves in accessible formulations. The approval does not change what is currently available to buy.

For consumers already using well-formulated mineral sunscreens with zinc oxide, nothing changes. Mineral sunscreens remain the only broadly available GRASE options and continue to offer excellent broad-spectrum coverage without systemic absorption concerns.

For consumers who find mineral sunscreens cosmetically problematic and currently rely on avobenzone-based chemical sunscreens, BEMT is a meaningful upgrade when it becomes available. Look for formulations at or near the 6% maximum concentration in combination with other stable filters. The first products to reach the market will likely be premium-priced; broader availability at accessible price points will take longer.

The approval also matters as a regulatory precedent. It is the first time the FDA has acted favorably on any of the organic filters awaiting review, and it demonstrates that the GRASE pathway for sunscreen ingredients can move forward with sufficient real-world evidence. Whether that translates into action on the other twelve pending filters remains to be seen.

References & Further Reading